Purespring Therapeutics
London gene therapy company targeting kidney podocytes to treat diseases such as IgA nephropathy.
purespringtx.com ↗Why it's here
Raised an oversubscribed £80M ($105M) Series B led by Sofinnova Partners in October 2024.
source: purespringtx.com- Focus
- Kidney Gene Therapy
- Founded
- 2020
- Total raised
- £115Msource: purespringtx.com
- Latest round
- Series B, £80M, Oct 2024
- London office
- Rolling Stock Yard, 188 York Way, Islington N7 9ASsource: purespringtx.com
- London presence
- HQsource: fiercebiotech.com
- Investors
- Sofinnova Partners (lead), British Patient Capital, Forbion, Gilde Healthcare, Synconasource: purespringtx.com
- Area
- King's Cross
- Nearest station
- Caledonian Road & Barnsbury, 580 m
- Companies House
- PURESPRING THERAPEUTICS LIMITED (12543677, active)Incorporated 1 Apr 2020 · SIC 72110
- Visas
- Licensed visa sponsor, listed as Purespring Therapeutics Limitedsource: gov.uk
Verified 6 Oct 2026. How we verify · Suggest a fix
For Purespring Therapeutics
Work here? Show you're on the map. Add the badge to your site or README, or share the listing.
<a href="https://londonmempool.co.uk/c/purespring-therapeutics"><img src="https://londonmempool.co.uk/badge/purespring-therapeutics.svg" alt="Purespring Therapeutics is listed on London Mempool" width="361" height="28"></a>
Add ?theme=light to the image URL for light backgrounds.
Same building
2 more companies on the map list this office address.